Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022;31(3):163-167.
doi: 10.1297/cpe.2022-0011. Epub 2022 Mar 30.

A case of adrenal insufficiency during multisystem inflammatory syndrome in children

Affiliations
Case Reports

A case of adrenal insufficiency during multisystem inflammatory syndrome in children

Fatih Kilci et al. Clin Pediatr Endocrinol. 2022.

Abstract

Multisystem inflammatory syndrome in children (MIS-C) is a disease related to coronavirus disease 2019 (COVID-19). Although the effects of COVID-19 on many systems are known, there is limited data regarding its effects on the endocrine system. This study aimed to discuss the effect of COVID-19 on cortisol dynamics in a patient who developed adrenal insufficiency after COVID-19 infection. An 11-yr-old boy with polymerase chain reaction-proven COVID-19 one month previously was referred with a five-day history of fever, vomiting, and rash. On admission, he had hypotension, tachycardia, and severe hyponatremia. After the evaluation, he was diagnosed with MIS-C and glucocorticoid therapy was initiated. During follow-up, the patient experienced adrenal insufficiency, and hydrocortisone treatment was initiated at a crisis dose. Four months later, the adrenal axis function had not recovered. The adrenocortical response in COVID-19 patients may be significantly impaired, resulting in increased mortality or morbidity.

Keywords: adrenal insufficiency; coronavirus disease 2019 (COVID-19); cortisol.

PubMed Disclaimer

Conflict of interest statement

The authors have nothing to declare.

References

    1. Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 2020;395: 1607–8. doi: 10.1016/S0140-6736(20)31094-1 - DOI - PMC - PubMed
    1. Ferraù F, Ceccato F, Cannavò S, Scaroni C. What we have to know about corticosteroids use during Sars-Cov-2 infection. J Endocrinol Invest 2021;44: 693–701. doi: 10.1007/s40618-020-01384-5 - DOI - PMC - PubMed
    1. Berni A, Malandrino D, Parenti G, Maggi M, Poggesi L, Peri A. Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: may all fit together? J Endocrinol Invest 2020;43: 1137–9. doi: 10.1007/s40618-020-01301-w - DOI - PMC - PubMed
    1. Bornstein SR, Ziegler CG, Krug AW, Kanczkowski W, Rettori V, McCann SM, et al. . The role of toll-like receptors in the immune-adrenal crosstalk. Ann N Y Acad Sci 2006;1088: 307–18. doi: 10.1196/annals.1366.027 - DOI - PubMed
    1. Pal R, Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest 2020;43: 1027–31. doi: 10.1007/s40618-020-01276-8 - DOI - PMC - PubMed

Publication types